Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Ori Biotech Ltd.
Headquarters: London, United Kingdom
Website: https://oribiotech.com/
Year Founded: 2015
Status: Private
BioCentury | Sep 14, 2022
Finance
Sept. 13 Quick Takes: Acelyrin heads for Phase III with $300M round
Plus note deals for Alnylam, Sarepta and updates from Rubius, Relay, Forge, Owkin, Ori and more
BioCentury | Jan 19, 2022
Product Development
Jan. 18 Quick Takes: Ori Biotech raises $100M series B
Plus nutrition co Faeth raises $20M; ADC/Tanabe deal, and updates from Dyne, Lilly, Abbisko and more
BioCentury | Jul 9, 2021
Management Tracks
Borio joins CEPI as SAB member; plus Aeglea, Codiak, Nordic Nanovector, BioShin and more
Luciana Borio, the senior fellow for global health at the Council on Foreign Relations, became a member of the scientific advisory board at Coalition for Epidemic Preparedness Innovations (CEPI).
BioCentury | Oct 15, 2020
Product Development
Oct. 14 Quick Takes: FDA approves first Ebola therapy; plus Vertex tumbles after hours on AAT discontinuation
Updates on Russia’s latest COVID-19 vaccine approval and more
Items per page:
1 - 4 of 4